Tradestie Institutional Equity Comparison Engine

ABSI vs RGNX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABSI Overall Edge

ABSI Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Absci Corporation Common Stock (ABSI) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while RGNX counters with relative strength in Valuation. Fundamentally, ABSI trades at N/M Forward P/E with -9108.3% operating margin (-19.6% YoY revenue) versus RGNX at N/M Forward P/E and -120.4% operating margin (-69.2% YoY). In options structure, ABSI sits in BREAKDOWN (15th %ile IV; Dealer Gamma Walls on Pro) against RGNX sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner RGNX
ABSI N/M vs RGNX N/M Fwd P/E
Growth & Margin Winner ABSI
Op Margin -9108.3% vs -120.4% ยท YoY -19.6% vs -69.2%
Momentum & Technical Winner ABSI
1Y +186.9% vs -36.0% ยท 52W Pos 52% vs 19%
Options & Structure Winner ABSI
BREAKDOWN (15th %ile IV) vs BREAKDOWN (52nd %ile IV)
ABSI NASDAQ
Absci Corporation Common Stock
Services-Commercial Physical & Biological Research
$7.58
-10.36% 1D
Market Cap $1.6B
1M Return -8.18%
1Y Return +186.93%
Forward P/E N/M
Unified AI Score
41.2 / 100 SELL
Tech 30.0 Fund 51.0 Flow 71.0 Mom 60.0
RGNX NASDAQ
REGENXBIO Inc.
Biological Products, (No Disgnostic Substances)
$7.45
-2.49% 1D
Market Cap $500.9M
1M Return +7.58%
1Y Return -36.0%
Forward P/E N/M
Unified AI Score
45.3 / 100 HOLD
Tech 36.0 Fund 44.0 Flow 69.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABSI +186.93% RGNX -36.0% Spread: +222.93 pp (ABSI Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ABSI Revenue RGNX Revenue ABSI Op. Margin RGNX Op. Margin Margin Edge
FY2018 N/A $220M N/A 40.3% RGNX
FY2019 N/A $40M N/A -422.9% RGNX
FY2020 $0M $150M -278.3% -77.1% RGNX
FY2021 $0M $470M -1573.4% 34.0% RGNX
FY2022 $10M $110M -1857.5% -233.2% RGNX
FY2023 $10M $90M -2020.2% -297.1% RGNX
FY2024 $0M $80M -2401.6% -280.0% RGNX
FY2025 $0M $170M -4297.0% -94.6% RGNX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABSI (5) vs RGNX (3)
Institutional Metric ABSI RGNX Criterion Row Winner
Market Capitalization Scale $1.6B $500.9M Larger Scale ABSI
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -19.6% -69.2% Higher Growth ABSI
Operating Margin (TTM) Profitability -9108.3% -120.4% Higher Margin RGNX
Net Profit Margin Profitability 0.0% -113.9% Higher Margin ABSI
Return on Equity (ROE) Capital Efficiency -58.6% -113.2% Higher ROE ABSI
52-Week Range Position Momentum 52% ($2โ€“$13) 19% ($5โ€“$16) Stronger Trend ABSI
Beta / 30D Volatility Risk Regime 3.32ฮฒ ยท 127% Vol 1.82ฮฒ ยท 76% Vol Lower Realized Risk RGNX
Unified Institutional Score Composite Signal 41.2 / 100 (SELL) 45.3 / 100 (HOLD) Higher Composite RGNX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABSI vs RGNX Buy Guide
ABSI BREAKDOWN
97d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live ABSI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RGNX BREAKDOWN
91d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 52nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live RGNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABSI nor RGNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.